Bioengineered human skin: working the bugs out.
作者信息
Steinstraesser L, Al-Benna S, Kesting M, Jacobsen F
机构信息
Department of Plastic and Reconstructive Surgery, Burn Center, BG University Hospital Bergmannsheil, Ruhr-University Bochum, Bochum, Nordrhein-Westfalen, Germany.
出版信息
Mol Ther. 2009 Mar;17(3):405-8. doi: 10.1038/mt.2009.14.
Abstract
摘要
相似文献
1
Bioengineered human skin: working the bugs out.
Mol Ther. 2009 Mar;17(3):405-8. doi: 10.1038/mt.2009.14.
2
FGF-7 expression enhances the performance of bioengineered skin.
Mol Ther. 2004 Jul;10(1):76-85. doi: 10.1016/j.ymthe.2004.04.013.
3
A Surgical Device to Study the Efficacy of Bioengineered Skin Substitutes in Mice Wound Healing Models.
Tissue Eng Part C Methods. 2017 Apr;23(4):237-242. doi: 10.1089/ten.tec.2016.0545. Epub 2017 Mar 23.
4
Advances in skin regeneration: application of electrospun scaffolds.
Adv Healthc Mater. 2015 Jun 3;4(8):1114-33. doi: 10.1002/adhm.201500001. Epub 2015 Feb 26.
5
Restoration of the transepithelial potential within tissue-engineered human skin in vitro and during the wound healing process in vivo.
Tissue Eng Part A. 2010 Oct;16(10):3055-63. doi: 10.1089/ten.TEA.2010.0030.
6
Bioengineered skin in diabetic foot ulcers.
Diabetes Obes Metab. 2010 Apr;12(4):307-15. doi: 10.1111/j.1463-1326.2009.01164.x.
7
MicroRNAs in skin tissue engineering.
Adv Drug Deliv Rev. 2015 Jul 1;88:16-36. doi: 10.1016/j.addr.2015.04.018. Epub 2015 May 4.
8
Biopolymers: Applications in wound healing and skin tissue engineering.
Mol Biol Rep. 2018 Dec;45(6):2857-2867. doi: 10.1007/s11033-018-4296-3. Epub 2018 Aug 9.
9
Tissue Engineered Skin and Wound Healing: Current Strategies and Future Directions.
Curr Pharm Des. 2017;23(24):3455-3482. doi: 10.2174/1381612823666170526094606.
10
Bioglass Activated Skin Tissue Engineering Constructs for Wound Healing.
ACS Appl Mater Interfaces. 2016 Jan 13;8(1):703-15. doi: 10.1021/acsami.5b09853. Epub 2015 Dec 31.
引用本文的文献
1
Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing.
Mol Ther. 2014 Apr;22(4):734-42. doi: 10.1038/mt.2013.258. Epub 2013 Dec 5.
2
Oncolytic activities of host defense peptides.
Int J Mol Sci. 2011;12(11):8027-51. doi: 10.3390/ijms12118027. Epub 2011 Nov 16.
3
Chimeric composite skin substitutes for delivery of autologous keratinocytes to promote tissue regeneration.
Ann Surg. 2010 Feb;251(2):368-76. doi: 10.1097/SLA.0b013e3181c1ab5f.
本文引用的文献
1
Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue.
Mol Ther. 2009 Mar;17(3):562-9. doi: 10.1038/mt.2008.289. Epub 2009 Feb 3.
2
Host defense peptides in wound healing.
Mol Med. 2008 Jul-Aug;14(7-8):528-37. doi: 10.2119/2008-00002.Steinstraesser.
3
Host defense peptides and the new line of defence against multiresistant infections.
Protein Pept Lett. 2008;15(3):238-43. doi: 10.2174/092986608783744252.
4
Host defence peptides in human burns.
Burns. 2008 Feb;34(1):32-40. doi: 10.1016/j.burns.2007.04.017. Epub 2007 Aug 21.
5
Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin.
J Antimicrob Chemother. 2007 Mar;59(3):493-8. doi: 10.1093/jac/dkl513. Epub 2007 Feb 8.
6
Adenoviral gene delivery to primary human cutaneous cells and burn wounds.
Mol Med. 2006 Sep-Oct;12(9-10):199-207. doi: 10.2119/2006-00031.Hirsch.
7
The human host defense peptide LL37/hCAP accelerates angiogenesis in PEGT/PBT biopolymers.
Ann Plast Surg. 2006 Jan;56(1):93-8. doi: 10.1097/01.sap.0000190883.30005.91.
8
Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.
Gene Ther. 2005 Oct;12(20):1494-502. doi: 10.1038/sj.gt.3302568.
9
Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure.
Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L842-8. doi: 10.1152/ajplung.00286.2004. Epub 2005 Jun 17.
10
Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.
J Immunol. 2005 May 15;174(10):6257-65. doi: 10.4049/jimmunol.174.10.6257.
Zotero 插件